Astragaloside IV exhibits anti-tumor function in gastric cancer via targeting circRNA dihydrolipoamide S-succinyltransferase (circDLST)/miR-489-3p/ eukaryotic translation initiation factor 4A1(EIF4A1) pathway

References

• Bray F, Ren JS, Masuyer E, et al. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132(5):1133–1145.
   PubMed Web of Science ®Google Scholar
• Cunningham SC, Kamangar F, KIM M, et al. Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution. J Gastrointest Surg. 2005;9(5):718–725.
   PubMed Web of Science ®Google Scholar
• Camargo MC, Kim W-H, Chiaravalli AM, et al. Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. Gut. 2014;63(2):236–243.
   PubMed Web of Science ®Google Scholar
• Ren S, Zhang H, Mu Y, et al. Pharmacological effects of Astragaloside IV: a literature review. J Tradit Chin Med. 2013;33(3):413–416.
   PubMed Web of Science ®Google Scholar
• Liu W, Chen H, Wang D. Protective role of astragaloside IV in gastric cancer through regulation of microRNA-195-5p-mediated PD-L1. Immunopharmacol Immunotoxicol. 2021;43(4):443–451.
   PubMed Web of Science ®Google Scholar
• Greene J, Baird AM, Brady L, et al. Circular RNAs: biogenesis, function and role in human diseases. Front Mol Biosci. 2017;4:38.
   PubMed Web of Science ®Google Scholar
• Sheng JQ, Liu L, Wang MR, et al. Circular RNAs in digestive system cancer: potential biomarkers and therapeutic targets. Am J Cancer Res. 2018;8(7):1142–1156.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu H, Li W, et al. CircRNA_100269 is downregulated in gastric cancer and suppresses tumor cell growth by targeting miR-630. Aging (Albany NY). 2017;9(6):1585–1594.
   PubMedGoogle Scholar
• Xin D, Xin Z. CircRNA_100782 promotes proliferation and metastasis of gastric cancer by downregulating tumor suppressor gene Rb by adsorbing miR-574-3p in a sponge form. Eur Rev Med Pharmacol Sci. 2020;24(17):8845–8854.
   PubMed Web of Science ®Google Scholar
• Peng L, Sang H, Wei S, et al. circCUL2 regulates gastric cancer malignant transformation and cisplatin resistance by modulating autophagy activation via miR-142-3p/ROCK2. Mol Cancer. 2020;19(1):156.
   PubMed Web of Science ®Google Scholar
• Zhang J, Hou L, Liang R, et al. Correction to: circDLST promotes the tumorigenesis and metastasis of gastric cancer by sponging miR-502-5p and activating the NRAS/MEK1/ERK1/2 signaling. Mol Cancer. 2020;19(1):125.
   PubMed Web of Science ®Google Scholar
• Cai H, Li Y, Niringiyumukiza JD, et al. Circular RNA involvement in aging: an emerging player with great potential. Mech Ageing Dev. 2019;178:16–24.
   PubMed Web of Science ®Google Scholar
• Yang X, Zhu X, Yan Z, et al. miR-489-3p/SIX1 axis regulates melanoma proliferation and glycolytic potential. Mol Ther Oncolytics. 2020;16:30–40.
   PubMed Web of Science ®Google Scholar
• Sun D, Li T, Xin H, et al. miR-489-3p inhibits proliferation and migration of bladder cancer cells through downregulation of histone deacetylase 2. Oncol Lett. 2020;20(4):8.
   PubMed Web of Science ®Google Scholar
• Zheng B, Chen T. MiR-489-3p inhibits cell proliferation, migration, and invasion, and induces apoptosis, by targeting the BDNF-mediated PI3K/AKT pathway in glioblastoma. Open Life Sci. 2020;15(1):274–283.
   PubMed Web of Science ®Google Scholar
• Ambros V. The functions of animal microRNAs. Nature. 2004;431(7006):350–355.
   PubMed Web of Science ®Google Scholar
• Garzon R, Marcucci G, Croce CM. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov. 2010;9(10):775–789.
   PubMed Web of Science ®Google Scholar
• Zhang H, Ji S, Ma F, et al. MiR-489 inhibited the development of gastric cancer via regulating HDAC7 and PI3K/AKT pathway. World J Surg Oncol. 2020;18(1):73.
   PubMed Web of Science ®Google Scholar
• Zhang B, et al. miR-489 acts as a tumor suppressor in human gastric cancer by targeting PROX1. Am J Cancer Res. 2016;6(9):2021–2030.
   PubMed Web of Science ®Google Scholar
• Hagner PR, Schneider A, Gartenhaus RB. Targeting the translational machinery as a novel treatment strategy for hematologic malignancies. Blood. 2010;115(11):2127–2135.
   PubMed Web of Science ®Google Scholar
• Tsumuraya T, Ishikawa C, Machijima Y, et al. Effects of hippuristanol, an inhibitor of eIF4A, on adult T-cell leukemia. Biochem Pharmacol. 2011;81(6):713–722.
   PubMed Web of Science ®Google Scholar
• Cencic R, Robert F, Galicia-Vázquez G, et al. Modifying chemotherapy response by targeted inhibition of eukaryotic initiation factor 4A. Blood Cancer J. 2013;3(7):e128.
   PubMed Web of Science ®Google Scholar
• Li C, Tian Y, Liang Y, et al. Circ_0008035 contributes to cell proliferation and inhibits apoptosis and ferroptosis in gastric cancer via miR-599/EIF4A1 axis. Cancer Cell Int. 2020;20(1):84.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Tian LJ, Wu Y-P, Wang D, et al. Upregulation of long noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is associated with cisplatin resistance in Non-Small Cell Lung Cancer (NSCLC) by downregulating microRNA-144-3p. Med Sci Monit. 2019;25:8095–8104.
   PubMed Web of Science ®Google Scholar
• Wu F, Wang F, Yang Q, et al. Upregulation of miRNA-23a-3p rescues high glucose-induced cell apoptosis and proliferation inhibition in cardiomyocytes. In Vitro Cell Dev Biol Anim. 2020;56(10):866–877.
   PubMed Web of Science ®Google Scholar
• Zhang W, Mao S, Shi D, et al. MicroRNA-153 decreases tryptophan catabolism and inhibits angiogenesis in bladder cancer by targeting indoleamine 2,3-dioxygenase 1. Front Oncol. 2019;9:619.
   PubMed Web of Science ®Google Scholar
• Sun J, Xin K, Leng C, et al. Down-regulation of SNHG16 alleviates the acute lung injury in sepsis rats through miR-128-3p/HMGB3 axis. BMC Pulm Med. 2021;21(1):191.
   PubMed Web of Science ®Google Scholar
• Xu F, Cui WQ, Wei Y, et al. Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling. J Exp Clin Cancer Res. 2018;37(1):207.
   PubMed Web of Science ®Google Scholar
• Lei X, Zhang L, Li Z, et al. Astragaloside IV/lncRNA-TUG1/TRAF5 signaling pathway participates in podocyte apoptosis of diabetic nephropathy rats. Drug Des Devel Ther. 2018;12:2785–2793.
   PubMed Web of Science ®Google Scholar
• Li H, Yao C, Shi K, et al. Astragaloside IV attenuates hypoxia/reoxygenation injury-induced apoptosis of type II alveolar epithelial cells through miR-21-5p. Bioengineered. 2021;12(1):7747–7754.
   PubMed Web of Science ®Google Scholar
• Zhang A, Zheng Y, Que Z, et al. Astragaloside IV inhibits progression of lung cancer by mediating immune function of Tregs and CTLs by interfering with IDO. J Cancer Res Clin Oncol. 2014;140(11):1883–1890.
   PubMed Web of Science ®Google Scholar
• Zhang J, Hou L, Liang R, et al. CircDLST promotes the tumorigenesis and metastasis of gastric cancer by sponging miR-502-5p and activating the NRAS/MEK1/ERK1/2 signaling. Mol Cancer. 2019;18(1):80.
   PubMed Web of Science ®Google Scholar
• Zhang L, Liu T, Chen H, et al. Predicting lncRNA-miRNA interactions based on interactome network and graphlet interaction. Genomics. 2021;113(3):874–880.
   PubMed Web of Science ®Google Scholar
• Wang CC, Han CD, Zhao Q, et al. Circular RNAs and complex diseases: from experimental results to computational models. Brief Bioinform. 2021;22(6). DOI:10.1093/bib/bbab286
   Web of Science ®Google Scholar
• Chen L, Chen L, Qin Z, et al. Upregulation of miR-489-3p and miR-630 inhibits oxaliplatin uptake in renal cell carcinoma by targeting OCT2. Acta Pharm Sin B. 2019;9(5):1008–1020.
   PubMed Web of Science ®Google Scholar
• Gao C, Guo X, Xue A, et al. High intratumoral expression of eIF4A1 promotes epithelial-to-mesenchymal transition and predicts unfavorable prognosis in gastric cancer. Acta Biochim Biophys Sin (Shanghai). 2020;52(3):310–319.
   PubMed Web of Science ®Google Scholar